Patrice S. Obermiller

Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

Marilyn E. Thompson, Roy A. Jensen, Patrice S. Obermiller et al. · Nature Genetics · 1995 · 587 citations

Medicine, Molecular Genetics, Oncology +10

Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes.

David S. Ucker, Patrice S. Obermiller, Walter Eckhart et al. · Molecular and Cellular Biology · 1992 · 224 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death

David S. Ucker, Jennifer Hartt Meyers, Patrice S. Obermiller · The Journal of Immunology · 1992 · 118 citations

Life Sciences, Cell Biology, Immunology +13

Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stability.

David L. Tait, Patrice S. Obermiller, A R Hatmaker et al. · PubMed · 1999 · 72 citations

Medicine, Immunology, Oncology +17

A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer.

David L. Tait, Patrice S. Obermiller, S Redlin-Frazier et al. · PubMed · 1997 · 66 citations

Medicine, Oncology, Pharmacokinetics +14